Cargando…
[(18)F]MK-7246 for Positron Emission Tomography Imaging of the Beta-Cell Surface Marker GPR44
The progressive loss of beta-cell mass is a hallmark of diabetes and has been suggested as a complementary approach to studying the progression of diabetes in contrast to the beta-cell function. Non-invasive nuclear medicinal imaging techniques such as Positron Emission Tomography using radiation em...
Autores principales: | Cheung, Pierre, Amin, Mohammad A., Zhang, Bo, Lechi, Francesco, Korsgren, Olle, Eriksson, Jonas, Odell, Luke R., Eriksson, Olof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962486/ https://www.ncbi.nlm.nih.gov/pubmed/36839820 http://dx.doi.org/10.3390/pharmaceutics15020499 |
Ejemplares similares
-
PET Imaging of GPR44 by Antagonist [(11)C]MK-7246 in Pigs
por: Cheung, Pierre, et al.
Publicado: (2021) -
GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass
por: Eriksson, Olof
Publicado: (2019) -
The development of a GPR44 targeting radioligand [(11)C]AZ12204657 for in vivo assessment of beta cell mass
por: Jahan, Mahabuba, et al.
Publicado: (2018) -
Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation
por: Eriksson, Olof, et al.
Publicado: (2016) -
UGT2B17 Genetic Polymorphisms Dramatically Affect the Pharmacokinetics of MK-7246 in Healthy Subjects in a First-in-Human Study
por: Wang, Y-H, et al.
Publicado: (2012)